Some Drugs and Herbal Products
Publisher: International Agency for Research on Cancer 2016
Number of pages: 438
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).
Home page url
Download or read it online for free here:
by Jessica Fulton, et al. - Department of Veterans Affairs
Palliative care improves quality of life by managing patients' physical symptoms and psychosocial distress, often provided concurrently with oncology care. Integration of palliative care services with oncology care is now considered standard ...
by Robyn Dewis, Jonathan Gribbin - National Collaborating Centre for Cancer
This is a summary of the current information available regarding the epidemiology of breast cancer regionally, nationally and internationally. Its purpose is to provide the guidelines on early and locally advanced and advanced breast cancer.
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
- World Health Organization
This publication gives a broad vision of what a comprehensive approach to cervical cancer prevention and control means. It outlines the complementary strategies, and highlights the need for collaboration across programmes, organizations and partners.